Researchers map key human proteins that power coronavirus replication, pointing to new treatment strategies Findings from Scripps Research reveal promising drug targets with potential to block coronaviruses at multiple stages of infection even across different strains.
September 05, 2025
LA JOLLA, CA Despite vaccines and treatments, SARS-CoV-2 the virus that causes COVID-19 continues to pose a global health threat, driven by new variants and its ability to hijack human cells in ways that still aren't fully understood. Now, scientists at Scripps Research have pinpointed dozens of human proteins that SARS-CoV-2 needs to complete its full life cycle, from entering a cell to replicating and releasing new viral particles.
Published in PLOS Biology on June 12, 2025, these findings could open the door to new drug strategies that target our own proteins rather than the virus itself, potentially leading to new treatments effective against SARS-CoV-2 and other coronaviruses, even as the pathogens continue to evolve.
To find out which human proteins SARS-CoV-2 relies on, the research team used a technique called genome-wide small interfering RNA (siRNA) screening. This method can individually inhibit human genes in cells that are naturally susceptible to SARS-CoV-2, revealing which proteins the virus requires to replicate. The team uncovered 32 proteins essential for the earliest stages of infection, 27 proteins that the virus uses later, as well as cellular pathways it exploits some previously known and others newly discovered.
Since the beginning of the pandemic, our lab has long been focused on antivirals that target SARS-CoV-2, but what this work underscores is the importance of shifting toward understanding how the virus interacts with the host, says Sumit Chanda, a professor of immunology and microbiology at Scripps Research and co-senior author of the study. By identifying the human proteins that coronaviruses rely on, we can now think about developing the next generation of pan-coronavirus therapies treatments that could be effective not just against today's SARS-CoV-2, but even a future SARS-CoV-3. Because these strategies target the host, they're also less likely to be undermined by viral mutations and drug resistance.
Among the proteins identified, two emerged as especially promising drug targets. The first, perlecan, is a large protein studded with sugar chains found in the extracellular matrix the supportive meshwork that surrounds and organizes our cells. The research team discovered that SARS-CoV-2's spike protein can latch directly onto perlecan's sugar chains, helping the virus attach to and enter human cells. Blocking that interaction could prevent infection from taking hold.
Perlecan could be acting almost like a co-receptor for the virus, says co-senior author Laura Martin-Sancho, who was formerly a staff research scientist at Scripps Research and is now an assistant professor of molecular virology at Imperial College London. If we can target that interaction, we may be able to stop infection right at the door.
The second protein, Baculoviral IAP Repeat Containing 2 (BIRC2), is part of a cellular inflammation pathway. In cultures of human cells and in mice infected with SARS-CoV-2, drug compounds known as second mitochondria-derived activators of caspases (Smac) mimetics originally developed to trigger cell death in cancer and to wake up dormant HIV so it can be targeted by the therapy successfully inhibited BIRC2, slashing viral levels in an animal model.
With BIRC2, the really striking part is that our lab had been working with Smac mimetics for years in HIV research, adds Chanda. To suddenly see them show antiviral activity against SARS-CoV-2 was a big surprise.
Importantly, the team tested the same human proteins against three other coronaviruses: SARS-CoV-1, MERS-CoV and a seasonal coronavirus. Of the 47 proteins tested, 17 were consistently used by all three viruses, including proteins that help viruses fuse with cells, copy themselves, and exit to infect new cells. This suggests that blocking human proteins that the viruses depend on could form the basis of drugs effective against past, current and potentially future pandemic coronaviruses. Because host-directed antivirals target human proteins rather than viral proteins, they're less likely to be undermined by the virus's rapid mutation rate.
If we have such antivirals ready ahead of time, we could deploy them early in a future coronavirus outbreak, points out Chanda. That gives us a higher barrier to resistance and the potential to block multiple viruses with a single therapy.
Next, the researchers plan to explore whether the same host proteins are also used by other respiratory pathogens such as influenza and RSV. They'll also continue testing the safety and efficacy of promising compounds in future studies.
Authors of the study, Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection, include Yuan Pu, Laura Riva, Paul D. De Jesus, Daniel Fuentes and Ignacio Mena of Scripps Research; Xin Yin of the Chinese Academy of Agricultural Sciences; Shuofeng Yuan of the Li Ka Shing Faculty of Medicine; Lars Pache of the Sanford Burnham Prebys Medical Discovery Institute; Christopher Churas, Thomas Clausen, Jeffrey D. Esko, Trey Ideker and Dexter Pratt of the University of California San Diego; Stuart Weston, Grace Biddle, Simon Doss-Gollin, Meagan Deming and Matthew B. Frieman of the University of Maryland School of Medicine; Lacy M. Simons, William J. Cisneros and Judd F. Hultquist of Northwestern University Feinberg School of Medicine; Ha Na Kim, John M. Whitelock and Megan S. Lord of the University of New South Wales; and Adolfo Garc a-Sastre of the Icahn School of Medicine at Mount Sinai.
This work was
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
02/05/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
01/05/2026
January 5 2026, 18:30 (PST) NBCUniversal's Peacock to Be First Streamer to ...
01/04/2026
January 4 2026, 18:00 (PST) DOLBY AND DOUYIN EMPOWER THE NEXT GENERATON OF CREATORS WITH DOLBY VISION
Douyin Users Can Now Create And Share Videos With Stun...
04/03/2026
Lega Basket Serie A (LBA), the governing body for Italy's premier basketball...
04/03/2026
Wrexham AFC co-chairmen Rob Mac and Ryan Reynolds will host a first-of-its-kind ...
04/03/2026
The countdown is underway and with just 100 days to go until the world's greatest sporting event begins on Thurs., June 11, FOX Sports, America's Englis...
04/03/2026
No matter where they are in the world, service members and veterans can stream N...
04/03/2026
Telemundo officially releases Somos M s, the anthem for the network's cove...
04/03/2026
The Hollywood Professional Association (HPA) concluded the 2026 HPA Tech Retreat, convening more than 800 industry leaders, technologists, creatives, and execut...
04/03/2026
Smith Entertainment Group transformed how local sports are consumed by creating ...
04/03/2026
The production method, which spans a distance of 36.2 miles, was designed and im...
04/03/2026
Haivision, a global provider of mission-critical, real-time video networking and...
04/03/2026
When Hugues Meyrath came out of retirement to take the helm as CEO of Quantum, i...
04/03/2026
Last week's launch of Banana Ball Championship League has spurred a significant upgrade of production facilities
The Savannah Bananas, arguably the hottest...
04/03/2026
sldkfjsdlfkjsldkfjsldkjfslkdjfslkdjfsl
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus...
04/03/2026
For many fans, a song's backstory can be just as compelling as the final pro...
04/03/2026
In 2006, Spotify was founded on the belief that technology could bring artists a...
04/03/2026
Spotify is back on the ground for the Houston Livestock Show and Rodeo, and we&#...
04/03/2026
Spotify had an energizing week in Sydney, Australia, filled with powerful conver...
04/03/2026
Earlier this year, we launched Directed By, a documentary-style series that pull...
04/03/2026
100 Days to Go: SBS Unveils World Class Team for The Greatest Show on Earth -The...
04/03/2026
KT and Rohde & Schwarz to showcase AI-enhanced radio transmission performance In a joint 6G AI proof-of-concept demonstration, the CMX500 one-box tester from ...
04/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
04/03/2026
Luxembourg, 3 March 2026 - SES S.A. has today published its 2025 Annual Report, following the announcement of the company's full year financial results for ...
04/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
04/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
04/03/2026
Luxembourg, March 3, 2026 - SES, a leading space solutions company, along with I...
04/03/2026
04 Mar 2026
VEON Partners with GSMA Innovation Fund to Accelerate Digital Innov...
04/03/2026
04 Mar 2026
VEON's Beeline Uzbekistan and Rakuten Symphony Partner for Open...
04/03/2026
Wednesday 4 March 2026
Sky Sports unveils plans for 2026 Formula 1 coverage
Sky Sports is preparing for one of the most highly anticipated F1 seasons in recen...
04/03/2026
Back to All News
Bloodhounds' Season 2 Gears Up for April 3 Premiere with ...
04/03/2026
Back to All News
Netflix Ads Suite Expands Capabilities
Business
04 March 2026
GlobalUnited States
Link copied to clipboard
After launching the Netflix Ad...
04/03/2026
Scripps Research welcomes healthcare innovator Joe Kiani to the Board of Directors Kiani brings decades of experience in patient safety and public service.
Mar...
04/03/2026
Nanoparticle vaccine approach takes on a new target: Hepatitis C virus Scripps Research scientists reengineer critical proteins on the surface of HCV, paving th...
03/03/2026
Beyond Sports, a Sony group company, and LIV Golf, the world's golf league, ...
03/03/2026
Ilitch Sports + Entertainment announces the launch of Detroit SportsNet (DSN), a year-round broadcast home for two of Detroit's franchises. With flexible op...
03/03/2026
Advanced Systems Group, LLC (ASG), a technology and services provider for media ...
03/03/2026
The PGA of America, NBC Sports and USA Sports extend their media rights agreemen...
03/03/2026
AI device ecosystem company HONOR enters into a strategic technical collaboratio...
03/03/2026
Cleveland's Telos Alliance, pioneers in broadcast technology for 30 years, l...
03/03/2026
The MD 9235 microphone head for wireless handhelds has been a firm favorite with many engineers and artists for its ability to cut through high on-stage levels ...
03/03/2026
Haivision Systems Inc. (Haivision), a global provider of mission-critical, real-...
03/03/2026
Broadcast Management Group (BMG) announces the expansion of its 62,000-square-fo...
03/03/2026
Maroon 5's musical tour in 2025 marked a leap forward in live audio as Monitor Engineer Dave Rupsch utilized Sennheiser's all-digital Spectera wireless ...
03/03/2026
Designed specifically for pro basketball, the renovated space at Gainbridge Fiel...
03/03/2026
As part of the move, former CEO Phillipp Lawo joins the broadcast-tech provider's Supervisory Board
Lawo has announced appointment of Jamie Dunn as chief e...
03/03/2026
A team of legendary announcers and analysts and a classic graphics look will bring the past to life
NBC Sports and Peacock will return to yesteryear for tonigh...
Researchers map key human proteins that power coronavirus replication, pointing to new treatment strategies Findings from Scripps Research reveal promising drug targets with potential to block coronaviruses at multiple stages of infection even across different strains.
